Predicate |
Object |
contentType |
Journal Article|Research Support, Non-U.S. Gov't |
endingPage |
882 |
issn |
0031-6970 1432-1041 |
issueIdentifier |
9 |
pageRange |
877-882 |
publicationName |
European Journal of Clinical Pharmacology |
startingPage |
877 |
bibliographicCitation |
Gao Y, Zhang L, Fu Q. CYP3A4*1G polymorphism is associated with lipid-lowering efficacy of atorvastatin but not of simvastatin. European Journal of Clinical Pharmacology. 2008 Jun 05;64(9):877–82. doi: 10.1007/s00228-008-0502-x. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6406231400f8fe45084f2f7ae8cc2040 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5990a7c0c3bcb59f348af51f0f633003 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_841480eb8a5b57624d515213150db3ad |
date |
2008-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://doi.org/10.1007/s00228-008-0502-x https://pubmed.ncbi.nlm.nih.gov/18528690 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3612 https://portal.issn.org/resource/ISSN/0031-6970 https://portal.issn.org/resource/ISSN/1432-1041 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/ |
title |
CYP3A4*1G polymorphism is associated with lipid-lowering efficacy of atorvastatin but not of simvastatin |
discusses |
http://id.nlm.nih.gov/mesh/M0029425 http://id.nlm.nih.gov/mesh/M0179294 http://id.nlm.nih.gov/mesh/M0001378 http://id.nlm.nih.gov/mesh/M0159612 http://id.nlm.nih.gov/mesh/M0018276 http://id.nlm.nih.gov/mesh/M0010246 http://id.nlm.nih.gov/mesh/M0082919 http://id.nlm.nih.gov/mesh/M0012591 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60823 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8078 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460048 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3d4216466641a66ae41510cb235ba416 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454 |